Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

Holyoake, T L and Allan, E K and Mountford, J C and Richmond, L and Harrison, S J and Elliott, M A and Jorgensen, H G (2003) Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. Blood, 102 (11). 654A-654A. 2420. ISSN 0006-4971

Abstract

Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.

ORCID iDs

Elliott, M A ORCID: https://orcid.org/0000-0002-9964-5671

• Share and Export
  

  RefWorksRIS (EndNote Online, Zotero, Ref manager, etc)RDF+XMLEndNoteASCII CitationOpenURL ContextObject in SpanMPEG-21 DIDLRIOXX2 XMLBibTeXAtomEP3 XMLDublin CoreRDF+N-TriplesMODSHTML CitationJSONData Cite XMLRDF+N3Multiline CSVOpenURL ContextObjectReferSimple MetadataMETS
• Item metadata

  Item type:	Article
  ID code:	34854
  Dates:	Date Event 16 November 2003 Published
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	21 Nov 2011 14:39
  Last modified:	11 Nov 2024 09:55
  URI:	https://strathprints.strath.ac.uk/id/eprint/34854